[Pharmacotherapy of Anxiety Disorders]

Fortschr Neurol Psychiatr. 2016 May;84(5):306-14. doi: 10.1055/s-0042-106764. Epub 2016 Jun 14.
[Article in German]

Abstract

Anxiety disorders belong to the most frequent psychiatric disorders according to epidemiological studies and are associated with a high economic burden. Panic disorder, generalized anxiety disorder, social anxiety disorder, and specific phobia belong to the most important clinical disorders. The etiology is complex, including genetic, neurobiological as well as psychosocial factors. With regard to treatment, both psychotherapy and medication can be employed according to current treatment guidelines. With regard to psychotherapy, cognitive behavioral therapy (CBT) represents the treatment of choice. As for pharmacological treatment, in particular modern antidepressants and pregabalin are recommended. However, several recommendations have to be considered in daily clinical practice.

Publication types

  • Review

MeSH terms

  • Anti-Anxiety Agents / adverse effects
  • Anti-Anxiety Agents / therapeutic use*
  • Antidepressive Agents / adverse effects
  • Antidepressive Agents / therapeutic use
  • Anxiety Disorders / diagnosis
  • Anxiety Disorders / drug therapy*
  • Anxiety Disorders / epidemiology
  • Anxiety Disorders / psychology
  • Cognitive Behavioral Therapy
  • Combined Modality Therapy
  • Cross-Sectional Studies
  • Humans
  • Panic Disorder / diagnosis
  • Panic Disorder / drug therapy
  • Panic Disorder / psychology
  • Phobia, Social / diagnosis
  • Phobia, Social / drug therapy
  • Phobia, Social / psychology
  • Phobic Disorders / diagnosis
  • Phobic Disorders / drug therapy
  • Phobic Disorders / psychology
  • Pregabalin / adverse effects
  • Pregabalin / therapeutic use

Substances

  • Anti-Anxiety Agents
  • Antidepressive Agents
  • Pregabalin